Inspection issues remain at Catalent Indiana plant, pharma companies say
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Noweesrilgrp ho t ik ton raI otmcon o sCpgbd s iiiteseBnlp mulnouseenaaus aeidfotm ctrutosurea itlemenrg hrtntruepoounusg otnglstnip .niutilsnrsneed h,aen a t fnIcchatieoissx nsruomf
a nwhorse-.vlop bclkE rgeniA ooaIaoaec oetirem gsgovet denoaDansU bn ied mfohh tv “Nl mFon .ataDdtmre tt euetrtsNtrs. fdtaidnnottdnetluoiC adrsi Oahki”etik aliNni rr S,v
-aa-oa- crlliaosnlrddyhs/wf mobln ,ctis-t reih ftnhtii5qb ini l
<2etcrnascaat rrrwirvnn7uo siu alEa,tuod0gv fnC
riagheo2aasiiaei1sytn Mar0cd sdne gwetm/-lir/veircatpto Do"hpsenOnIpasitm nninoiarleor c2mnlic"ceeizumtoogu-0cerapho m-oN-dptaufspceatsffsat:aesatbtnsierddt8e snmhiotis’npua eaodo cciot.n tctpt gotpsmtdflhfaccnfcouioeawtaa neD r =o i1g/ aantith-ph ochfiev tsrri11vnldneiri o2ihte/iaifAngls/t et, ke tt8t h- n h d /aunscoilpgrt afmce>on-ecd r-enerw Nma dn ntlrgsd.nw hthoh.-o iFihi dc vauiiao rt sisdu-ts ecatnotinsn t5eo laoneroem, senlntta 9 talen
goTrohiil ptrNpryio akt r lovNFtounnglrdo ystocloac Do fcgeocerr emA aatisrv r ua ot ley.o ade ne
e amli oo addh,se tpmwp rcmr boecpohrsass nmtdiIdC ah eeieaeut cclidR palarvr ucatd totoehr,u bgiwigh l nor,amenapCe a rihc llMbpS ci,ilasagoasl.y eloykae ncnlcterteucnulitfct odantnsdaratahu tmtsp aeahdfa threttnbtihand aennsf, ioh sbta
tIyircuqincottrs e nsnrod asitm aenontsv n eacoh ey i Acrrm rAeoecgnqeinndrld hCtT t reiaideksipht ldhpnet nnteletia e mht F iu reiciteierI d"a sgsgns o"CftSyepem lopyrttirrcdccaces asetalene o lvaotoruDl d F n te o ph eeDosnehtatluLcrtbl Lwsrrciedundeiaawtet"doen rt i,Rahdttuho"o ameia.ais.ihsaa she
rd e aoo scpAcenpDhpbdantfalsirt"h cbiuwstmcnochtd pFumdtestnwr"D h,Bi dtkan eAao saS f FetosoflitetAniihi, n l orot seearao u.oletiitgcLsntnar fh,c l or o a ieiac isctctn RCieedtcIgLruiti uislgBaA unh i
